Conditioning Electrical Stimulation to Improve Outcomes in Cubital Tunnel Syndrome
Launched by UNIVERSITY OF ALBERTA · May 24, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called electrical stimulation to help improve recovery for patients with cubital tunnel syndrome, which is a condition that can cause pain and numbness in the arm due to pressure on the ulnar nerve. The trial aims to find out if this type of stimulation can speed up the healing of the nerve and enhance overall outcomes, especially in more severe cases where surgery alone may not be enough to help patients regain full function.
To participate in this trial, people need to be over 18 years old and have been diagnosed with severe cubital tunnel syndrome, which can be determined through specific tests. However, individuals with other nerve injuries, previous surgeries for this condition, or certain neurological issues won’t be eligible to join. If someone qualifies and decides to participate, they can expect to receive the electrical stimulation treatment and be monitored closely to see how well it works in improving their symptoms. This study is currently recruiting participants, so there is an opportunity for those who meet the criteria to take part in this important research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients aged \>18 yr,
- • 2. If signs and symptoms of severe CuTS (ie, McGowan-Goldberg grade 3) were observed,
- • 3. If needle EMG examination showed evidence of chronic motor axonal loss and reduced recruitment in the ulnar-innervated intrinsic hand muscles, and
- • 4. If electrophysiologic evidence of severe motor axonal loss with motor unit number estimation (MUNE) greater than 2 standard deviations below the normative mean.
- Exclusion Criteria:
- • 1) Patients were excluded if they had concurrent nerve injury, prior surgery for CuTS or coexisting neurologic conditions
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials